IHDG

51.7700.43%

Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration

In Salt Lake City, Carterra® has partnered with AstraZeneca to enhance lab-in-the loop drug discovery. Carterra®, known for its high-throughput surface plasmon resonance platforms, will collaborate with AstraZeneca to create hardware and software solutions. This partnership aims to bolster drug discovery by integrating laboratory systems, software, and data infrastructure with AI-powered workflows. The collaboration signifies a joint effort to advance research in this field.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.